Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
EI-001
BIOLOGICAL
2 trials
Sponsors
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Conditions
Healthy
Non-segmental Vitiligo
Phase 1
First in Human Study of EI-001 Monoclonal Antibody in Healthy Volunteers
Completed
NCT04994912
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Healthy
Start: 2021-10-01
End: 2025-02-18
Updated: 2025-06-24
Phase 2
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Recruiting
NCT07223229
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Non-segmental Vitiligo
Start: 2025-12-30
End: 2027-09-30
Target: 45
Updated: 2026-06-05